2024 annual financial data
Bionano Genomics 2024 Net margin
Direct answer
Net margin was -363.98%.
Operating income was -103,983,000 USD and net income was -112,017,000 USD.
Operating cash flow was -68,922,000 USD.
Get free Bionano Genomics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 30,776,000 USD
- Operating income
- -103,983,000 USD
- Net income
- -112,017,000 USD
- Operating cash flow
- -68,922,000 USD